Jazz Pharmaceuticals joins AstraZeneca and Lilly on Box's client list

Jazz Pharmaceuticals ($JAZZ) and Boston Scientific ($BSX) have begun using Box as their main platform for managing and collaborating on content. The companies join AstraZeneca ($AZN), Eli Lilly ($LLY) and Edwards Lifesciences on Box's list of life science clients. "Cloud technologies like Box have allowed us to remain nimble," AstraZeneca CIO David Smoley said in a statement. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.

Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.